EBIT: Income before interest and taxes.
Annovis Bio, Inc. (ANVS) had EBIT of $-6.28M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-5.54M |
|
-- |
|
-- |
|
$6.28M |
|
$-6.28M |
|
$0.75M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
|
EBIT |
$-6.28M |
$-6.28M |
|
17.43M |
|
17.43M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$26.74M |
|
-- |
|
-- |
|
$26.74M |
|
$2.50M |
|
-- |
|
$0.18M |
|
$2.68M |
|
$24.05M |
|
$24.05M |
|
$24.05M |
|
19.49M |
|
| Cash Flow Statement Financials | |
$-8.10M |
|
-- |
|
$19.78M |
|
$10.55M |
|
$22.24M |
|
$11.68M |
|
$0.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.02% |
|
-23.02% |
|
-20.71% |
|
-23.02% |
|
$1.23 |
|
$-0.46 |
|
$-0.46 |
|